Editorials: Inactivated vaccines protection against COVID-19 symptomatic infections
Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recen...
Gespeichert in:
Veröffentlicht in: | Clinical ehealth 2023-12, Vol.6, p.1-2 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Omicron variants of SARS-CoV-2 have been become the dominant variant family among more than 100 countries and regions around the world. There are still limited data on how inactivated COVID-19 vaccines prevent Omicron-related symptomatic infection, transmission, hospital admission, and death3. Recently, Dawei Yang et al. published a paper in the to explore the effect of inactivated COVID-19 vaccines on Omicron from the perspective of real-world observation data. |
---|---|
ISSN: | 2588-9141 2588-9141 |
DOI: | 10.1016/j.ceh.2023.04.001 |